Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.11.03.764009

Developing synthetic auxin-based trans-kingdom signaling

Abstract

Synthetic trans-kingdom signaling systems with tunable transduction properties provide a unique avenue to explore how communication between organisms coordinate behaviors without the confounding complexity of natural systems. However, existing trans-kingdom signaling systems suffer from either toxic signal molecules, a need for rare precursors for signal generation, or transduction machinery which is either species-specific or cannot be easily tuned. This limits their capacity to be broadly applied across kingdoms and their utility as a model system to study trans-kingdom interactions. In this work we elucidate the design principles for a trans-kingdom signaling system based on the plant phytohormone, Indole 3-Acetic Acid (auxin), that overcomes these challenges. We demonstrate how auxin biosynthesis can be engineered into a model sender organism, the cyanobacteria Synechococcus elongatus PCC 7942, and how this signal can be tuned with low leak and high dynamic range. We also show these signals can be connected to gene expression using tunable synthetic auxin-responsive signaling systems across multiple kingdoms. We demonstrate that S. elongatus generated auxin signals can tune gene expression in co-cultured Saccharomyces cerevisiae via auxin-induced degradation. Additionally, we show that when the S. elongatus are associated with the roots of the model plant, Arabidopsis thaliana, the auxin they generate can control gene expression via auxin-responsive synthetic transcription factors expressed from the plants genome. Taken together, our results demonstrate the design principles for a tunable auxin-based trans-kingdom signaling system that can be broadly applied across species.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Furnish, M., Kokarakis, E. J., Kopycienski, D., Thune-Larsen, B., Ducat, D. C., Khakhar, A.. 2026-11-04. Developing synthetic auxin-based trans-kingdom signaling. https://doi.org/10.64898/2026.11.03.764009

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Biosensor-guided genome-wide CRISPR screens enable cis,cis-muconic acid overproduction in yeast

Classical pathway metabolic engineering relies on enhancing strain productivity through the introduction of rationally identified genetic perturbations, which while useful, are time-consuming and miss unintuitive targets. Genome-wide CRISPR screens offer an alternative by efficiently sampling genomes, enabling the engineering of novel phenotypes, and are further enhanced when combined with high-throughput strain interrogation methods. Here, using Saccharomyces cerevisiae, we engineered small molecule biosensors into population enrichment tools using zeocin resistance and fluorescence as signal outputs. We then introduced the multi-functional genome-wide CRISPR (MAGIC) library that targets every gene for activation, interference, or deletion, thus creating biosensor-aided MAGIC, or senMAGIC. As a case study, we utilized senMAGIC to identify single genetic determinants that improve productivity of the nylon precursors protocatechuic and cis,cis-muconic acids (PCA and ccM). These were then randomly assembled as triple gRNA-tRNA arrays for multiplexed gene perturbations to identify combinatorial effects. Top gRNA hits were then confirmed using direct genomic integrations in senMAGIC-free production strains, resulting in identifying known as well as novel targets that increase PCA and ccM titres. Our results demonstrate senMAGIC as a robust automation-friendly whole-genome evolution tool and highlight limitations of the method, providing a roadmap for future multifunctional CRISPR screens to optimize host metabolism for efficient bioprocesses.

synthetic biology↗

Synthetic reaction-diffusion patterning in mammalian cells

During development, periodic patterns arise through reaction-diffusion (RD) circuits involving local activation and long-range inhibition (LALI). Natural systems are complex, typically entangling regulation and transport in the same morphogens. It remains unclear what minimal circuits are sufficient for LALI patterning in mammalian cells, and whether they can be implemented in a modular fashion, allowing independent control of regulation and transport. Here, we designed synthetic LALI circuits using three natural and synthetic signaling systems, BMP, Activin, and the SNIPR pathway, and showed that they generate spatial patterns with distinct characteristic spatial scales. Model-guided design allowed flexible morphogen reassignment, with BMP4 acting as either short-range activator or long-range inhibitor. Gene expression noise degraded long-range order but preserved the dominant local spatial scale. Together, these results provide a modular, extensible synthetic framework for engineered patterning in mammalian cells.

synthetic biology↗

Targeted cancer ablation via programmable sensing of amplified oncogenic RNA

Selectively eliminating cancer cells based on their oncogenic drivers holds great promise but remains challenging for targeted cancer therapy. Here, we present ORCA (Oncogenic RNA-triggered Cancer Ablation), a programmable and modular platform that couples RADAR-based detection of oncogenic RNA with conditional expression of therapeutic payloads in cancer cells. We identify RADAR sensors targeting the transcripts of endogenously amplified oncogenes, including MYC, FGFR2 and wild-type KRAS in colorectal and gastric cancer cells. Focusing on colorectal cancer (CRC) driven by extrachromosomal DNA-amplified MYC, we demonstrate targeted ablation of high-MYC cancer cells using two orthogonal strategies: anti-CD19 CAR-T therapy and enzyme-prodrug therapy. In vivo delivery of ORCA using adeno-associated virus (AAV) suppresses tumor growth in a subcutaneous xenograft model and prolongs survival in a CRC liver metastasis model. ORCA establishes oncogenic RNAs as actionable inputs for targeted cancer therapy via programmable RNA sensing, thus offering a strategy to target tumors through the transcripts of otherwise difficult-to-drug oncogenes such as MYC.

synthetic biology↗